Cost-benefit Analysis of Screening for Toxoplasmosis during Pregnancy

References

• Stagno S. Congenital toxoplasmosis: marginal comment. Am J Dis Child 1980; 134: 635–637
   PubMedGoogle Scholar
• Wilson C. B., Remington J. S. What can be done to prevent congenital toxoplasmosis?. Am J Obstet Gynecol 1980; 138: 357–363
   PubMed Web of Science ®Google Scholar
• McCabe R., Remington J. S. Toxoplasmosis: the time has come. N Engl J Med 1988; 318: 313–315
   PubMed Web of Science ®Google Scholar
• Foulon W., Naessens A., Lauwers S., de Meuter F., Amy J-J. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstet Gynecol 1988; 72: 363–366
   PubMed Web of Science ®Google Scholar
• Carter A. O., Gelmon S. B., Wells G. A., Toepell A. P. The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis. Epidemiol Infect 1989; 103: 539–545
   PubMed Web of Science ®Google Scholar
• Conyn-van Spaendonck M. AE, van Knapen F. Choices in preventive strategies: experience with the prevention of congenital toxoplasmosis in The Netherlands. Scand J Infect Dis Suppl 1992; 84: 51–58
   PubMedGoogle Scholar
• Ho-Yen D. O., Chatterton J. MW. Congenital toxoplasmosis why and how to screen. Rev Med Microbiol 1990; 1: 229–235
   Google Scholar
• Desmonts G. Preventing congenital toxoplasmosis. Lancet 1990; 336: 1017–1018
   PubMed Web of Science ®Google Scholar
• Anonymous. No UK prenatal toxoplasmosis screening. Lancet 1992; 339: 1291
   Google Scholar
• Marteau T. M. Reducing the psychological costs. BMJ 1990; 301: 26–28
   PubMed Web of Science ®Google Scholar
• Salmon R. L. Screening for toxoplasma in pregnancy. Lancet 1988; 2: 1085–1086
   PubMedGoogle Scholar
• Thorp J. M., Seeds J. W., Herbert W. NP, Bowes W. A., Maslow A. S., Cefalo R. C., Chescheir N., Katz V. L. Prenatal management and congenital toxoplasmosis. N Engl J Med 1988; 319: 372–373
   PubMed Web of Science ®Google Scholar
• Hohlfeld P., Daffos F., Costa J-M, Thulliez P., Forestier F., Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 1994; 331: 695–699
   PubMed Web of Science ®Google Scholar
• Lappalainen M., Koskela P., Hedman K., Teramo K., Ämmälä P., Hiilesmaa V., Koskiniemi M. Incidence of primary toxoplasma infections during pregnancy in southern Finland: a prospective cohort study. Scand J Infect Dis 1992; 24: 97–104
   PubMed Web of Science ®Google Scholar
• Pauker S. G., Kassirer J. P. Decision analysis. N Engl J Med 1987; 316: 250–258
   PubMed Web of Science ®Google Scholar
• Lappalainen M., Koskela P., Koskiniemi M., Ämmälä P., Hiilesmaa V., Teramo K., Raivio K. O., Remington J. S., Hedman K. Toxoplasmosis acquired during pregnancy: improved serodingnosis based on avidity of IgG. J Infect Dis 1998; 167: 691–697
   Google Scholar
• Roberts T., Frenkel J. Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. J Am Vet Med Assoc 1990; 196: 249–256
   PubMed Web of Science ®Google Scholar
• Stray-Pedersen B., Jenum P. Economic evaluation of preventive programmes against congenital toxoplasmosis. Scand J Infect Dis Suppl 1992; 84: 86–96
   PubMedGoogle Scholar
• Statistics of activities and expenses in different branches of specialities. The Finnish Hospital League, Helsinki 1988
   Google Scholar
• The Statistical Yearbook of Finland 1991. Helsinki. Central Statistical Office of Finland. 1991
   Google Scholar
• Ruusinen A. The use and fees of medical services in health centers. Payment policy, part 3. Helsinki. Ministry of Social Affairs and Health, Research Department. 1981
   Google Scholar
• Remington J. S., Desmonts G. Toxoplasmosis. Infectious Diseases of the Fetus and Newborn Infant, 3rd ed, J. S. Remington, J. O. Klein. WB Saunders, Philadelphia 1990; 89–195
   Google Scholar
• Lappalainen M., Koskiniemi M., Hiilesmaa V., Ämmälä P., Teramo K., Koskela P., Lebech M., Raivio K. O., Hedman L. The Study Group. Outcome of children after maternal primary toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. Pediatr Infect Dis J 1995; 14: 354–361, [in press]
   PubMedGoogle Scholar
• Joss A. WL, Chatterton J. MW, Ho-Yen D. O. Congenital toxoplasmosis: to screen or not to screen?. Public Health 1990; 104: 9–20
   PubMed Web of Science ®Google Scholar
• Stray-Pedersen B. Cost-benefit analysis of different programs to prevent congenital TORCH-infections. Proceedings of the International Symposium on Progress in Perinatal Medicine. 1983, 229–37
   Google Scholar
• Roos T., Martius J., Gross U., Schrod L. Systematic serologic screening for toxoplasmosis in pregnancy. Obstet Gynecol 1993; 81: 243–250
   PubMedGoogle Scholar
• Forsgren M., Gille E., Ljungström I., Nokes D. J. Toxoplasmagondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987. Lancet 1991; 337: 1413–1414
   PubMed Web of Science ®Google Scholar
• Stray-Pedersen B., Jenum P. Current status of toxoplasmosis in pregnancy in Norway. Scand J Infect Dis Suppl 1992; 84: 80–83
   PubMedGoogle Scholar
• In: Human Toxoplasmosis, D. O. Ho-Yen, A. WL Joss. Oxford University Press, Oxford 1992; 1–265
   Google Scholar
• Couvreur J., Desmonts G., Thulliez P. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. Spiramycin reassessed, P. Davey, J-C Pechere, D. Speller. Academic Press, Singapore 1988; 193–200
   Google Scholar
• Daffos F., Forestier F., Capella-Pavlovsky M., Thulliez P., Aufrant C., Valenti D., Cox W. L. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988; 318: 271–275
   PubMed Web of Science ®Google Scholar
• Guerina N. G., Hsu H-W, Meissner H. C., Maguire J. H., Lynfield R., Stechenberg B., Abroms I., Pasternack M. S., Hoff R., Eaton R. B., Grady G. F., the New England Regional Toxoplasma Working Group. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 1994; 330: 1858–1863, and
   PubMed Web of Science ®Google Scholar
• Editorial. Discounting health care: only a matter of timing?. Lancet 1992; 340: 148–149
   PubMedGoogle Scholar
• Wilson C. B., Remington J. S., Stagno S., Reynolds D. W. Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 1980; 66: 767–774
   PubMed Web of Science ®Google Scholar
• Koppe J. G., Loewer-Sieger D. H., de Roever-Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986; 1: 254–256
   PubMed Web of Science ®Google Scholar
• McCabe R., Remington J. S. Prenatal management and congenital toxoplasmosis. N Engl J Med 1988; 319: 373–374
   Google Scholar
• Editorial. Antenatal screening for toxoplasmosis in the UK. Lancet 1990; 336: 346–348
   PubMedGoogle Scholar
• Hall S. M. Congenital toxoplasmosis. BMJ 1992; 305: 291–297
   PubMedGoogle Scholar
• Henderson J., Beattie C., Hale E., Wright T. The evaluation of new services: possibilities for preventing congenital toxoplasmosis. Int J Epidemiol 1984; 13: 65–72
   PubMed Web of Science ®Google Scholar
• Peckham C. S., Logan S. Screening for toxoplasmosis during pregnancy. Arch Dis Child 1993; 68: 3–5
   PubMedGoogle Scholar